| Symbol |
Name |
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKR1C4
|
aldo-keto reductase family 1, member C4
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ATF3
|
activating transcription factor 3
|
|
ATF4
|
activating transcription factor 4
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CKB
|
creatine kinase, brain
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CST8
|
cystatin 8 (cystatin-related epididymal specific)
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EP300
|
E1A binding protein p300
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FHL2
|
four and a half LIM domains 2
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXA2
|
forkhead box A2
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
GATA2
|
GATA binding protein 2
|
|
HOXB2
|
homeobox B2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IL6
|
interleukin 6
|
|
KITLG
|
KIT ligand
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
MAK
|
male germ cell-associated kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult
|
|
MYOD1
|
myogenic differentiation 1
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NANOG
|
Nanog homeobox
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
ORM1
|
orosomucoid 1
|
|
ORM2
|
orosomucoid 2
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PHB
|
prohibitin
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PIP
|
prolactin-induced protein
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRL
|
prolactin
|
|
PSEN1
|
presenilin 1
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RB1
|
retinoblastoma 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS7
|
ribosomal protein S7
|
|
S100A11
|
S100 calcium binding protein A11
|
|
SAR1A
|
secretion associated, Ras related GTPase 1A
|
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
|
SHBG
|
sex hormone-binding globulin
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
|
|
SMARCA4
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TOP2B
|
topoisomerase (DNA) II beta 180kDa
|
|
TSC2
|
tuberous sclerosis 2
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B17
|
UDP glucuronosyltransferase 2 family, polypeptide B17
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
